Oncternal Therapeutics, Inc. (ONCT): Price and Financial Metrics
Oncternal Therapeutics, Inc. (ONCT)
Today's Latest Price: $2.64 USD
0.28 (-9.59%)
Updated Dec 2 4:00pm
Add ONCT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ONCT Stock Summary
- The ratio of debt to operating expenses for Oncternal Therapeutics Inc is higher than it is for about just 5.62% of US stocks.
- With a price/sales ratio of 25.87, Oncternal Therapeutics Inc has a higher such ratio than 92.83% of stocks in our set.
- As for revenue growth, note that ONCT's revenue has grown 107.06% over the past 12 months; that beats the revenue growth of 94.83% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Oncternal Therapeutics Inc, a group of peers worth examining would be SNSS, QUIK, AVEO, AKBA, and SILC.
- Visit ONCT's SEC page to see the company's official filings. To visit the company's web site, go to www.oncternal.com.
ONCT Stock Price Chart Interactive Chart >
ONCT Price/Volume Stats
| Current price | $2.64 | 52-week high | $6.28 |
| Prev. close | $2.92 | 52-week low | $1.49 |
| Day low | $2.60 | Volume | 1,398,926 |
| Day high | $2.82 | Avg. volume | 739,912 |
| 50-day MA | $2.43 | Dividend yield | N/A |
| 200-day MA | $2.72 | Market Cap | 59.00M |
Oncternal Therapeutics, Inc. (ONCT) Company Bio
Oncternal Therapeutics (formerly GTx, Inc.), a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules for the treatment of breast and prostate cancer, and other serious medical conditions. The company was founded in 1997 and is based in Memphis, Tennessee.
Loading social stream, please wait...